1
|
Ajmal M, Mahato AK, Khan M, Rawat S, Husain A, Almalki EB, Alzahrani MA, Haque A, Hakme MJM, Albalawi AS, Rashid M. Significance of Triazole in Medicinal Chemistry: Advancement in Drug Design, Reward and Biological Activity. Chem Biodivers 2024; 21:e202400637. [PMID: 38740555 DOI: 10.1002/cbdv.202400637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2024] [Revised: 05/09/2024] [Accepted: 05/13/2024] [Indexed: 05/16/2024]
Abstract
One of the triazole tautomers, 1,2,4-triazole derivatives, has a wide range of biological activities that suggest its potential therapeutic utility in medicinal chemistry. These actions include anti-inflammatory, anti-cancer, anti-bacterial, anti-tuberculosis, and anti-diabetic effects. Using computational simulations and models, we investigate the structure-activity relationships of 1,2,4-triazoles, showing how various modifications to the triazole core yield a variety of clinical therapeutic benefits. The review highlights the anti-inflammatory effect of 1,2,4-triazoles in relation to their ability to disrupt significant inflammatory mediators and pathways. We present in-silico data that illuminate the triazoles' capacity to inhibit cell division, encourage apoptosis, and stop metastasis in a range of cancer models. This review looks at the bactericidal and bacteriostatic properties of 1,2,4-triazole derivatives, with a focus on their potential efficacy against multi-drug resistant bacterial infections and their usage in tuberculosis therapy. In order to better understand these substances' potential anti-diabetic benefits, this review also looks at how they affect glucose metabolism regulation and insulin responsiveness. Coordinated efforts are required to translate the efficacy of 1,2,4-triazole compounds in preclinical models into practical therapeutic benefits. Based on the information provided, it can be concluded that 1,2,4-triazole derivatives are a promising class of diverse therapeutic agents with potential utility in a range of disorders. Their development and improvement might herald a new era of medical care that will be immensely advantageous to both patients and the medical community as a whole. This comprehensive research, which is further reinforced by in-silico investigations, highlights the great medicinal potential of 1,2,4-triazoles. Additionally, this study encourages more research into these substances and their enhancement for use in pharmaceutical development.
Collapse
Affiliation(s)
- Mohammad Ajmal
- School of Pharmaceutical Sciences & Technology, Sardar Bhagwan Singh University, Dehradun, 248001, Uttarakhand, India
| | - Arun Kumar Mahato
- School of Pharmaceutical Sciences & Technology, Sardar Bhagwan Singh University, Dehradun, 248001, Uttarakhand, India
| | - Mausin Khan
- School of Pharmaceutical Sciences & Technology, Sardar Bhagwan Singh University, Dehradun, 248001, Uttarakhand, India
| | - Shivani Rawat
- School of Pharmaceutical Sciences & Technology, Sardar Bhagwan Singh University, Dehradun, 248001, Uttarakhand, India
| | - Asif Husain
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110064, India
| | | | | | - Anzarul Haque
- Central Laboratories Unit, Qatar University, Doha, 2713, Qatar
| | | | - Ahmed Suleman Albalawi
- Tabuk Health Cluster, Erada Mental Health Complex, Tabuk, 47717, Kingdom of Saudi Arabia
| | - Mohammad Rashid
- Department of Pharmacognosy and Pharmaceutical Chemistry, College of Dentistry and Pharmacy, Buraydah Private Colleges, Buraydah, 51418, Saudi Arabia
| |
Collapse
|
2
|
Zhu H, Zhong X. Honokiol as an α-glucosidase inhibitor. Front Pharmacol 2024; 15:1425832. [PMID: 38962316 PMCID: PMC11220239 DOI: 10.3389/fphar.2024.1425832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Accepted: 06/04/2024] [Indexed: 07/05/2024] Open
Abstract
Honokiol, a naturally occurring compound from Magnolia obovata Thunb., has many biological activities, but its anti-α-glucosidase activity is still unclear. Therefore, we determined its inhibitory effects against α-glucosidase. Activity assays showed that honokiol was a reversible mixed-type inhibitor of α-glucosidase, and its IC50 value was 317.11 ± 12.86 μM. Fluorescence results indicated that the binding of honokiol to α-glucosidase caused a reduction in α-glucosidase activity. 3D fluorescence and CD spectra results indicated that the binding of honokiol to α-glucosidase caused conformational change in α-glucosidase. Docking simulated the detailed interactions between honokiol and α-glucosidase, including hydrogen and hydrophobic bonds. All findings showed that honokiol could be used as a natural inhibitor to develop α-glucosidase agents.
Collapse
Affiliation(s)
- Hua Zhu
- School of Chemistry and Chemical Engineering, Mianyang Teacher’s College, Mianyang, China
| | - Xin Zhong
- Dean’s Office, Mianyang Teacher’s College, Mianyang, China
| |
Collapse
|
3
|
Ali M, Malik K, Zaidi A, Farooq U, Bukhari SM, Majeed Z, Mahnashi MH, Nawazish S, Abdulwahab A, Alshaibari KS. In-vitro high-throughput library screening-Kinetics and molecular docking studies of potent inhibitors of α-glucosidase. PLoS One 2023; 18:e0286159. [PMID: 37390110 PMCID: PMC10313066 DOI: 10.1371/journal.pone.0286159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Accepted: 05/09/2023] [Indexed: 07/02/2023] Open
Abstract
High throughput screening of synthetic compounds against vital enzymes is the way forward for the determination of potent enzyme inhibitors. In-vitro high throughput library screening of 258 synthetic compounds (comp. 1-258), was performed against α-glucosidase. The active compounds out of this library were investigated for their mode of inhibition and binding affinities towards α-glucosidase through kinetics as well as molecular docking studies. Out of all the compounds selected for this study, 63 compounds were found active within the IC50 range of 3.2 μM to 50.0 μM. The most potent inhibitor of α-glucosidase out of this library was the derivative of an oxadiazole (comp. 25). It showed the IC50 value of 3.23 ± 0.8 μM. Other highly active compounds were the derivatives of ethyl-thio benzimidazolyl acetohydrazide with IC50 values of 6.1 ± 0.5 μM (comp. 228), 6.84 ± 1.3 μM (comp. 212), 7.34 ± 0.3 μM (comp. 230) and 8.93 ± 1.0 μM (comp. 210). For comparison, the standard (acarbose) showed IC50 = 378.2 ± 0.12 μM. Kinetic studies of oxadiazole (comp. 25) and ethylthio benzimidazolyl acetohydrazide (comp. 228) derivatives indicated that Vmax and Km, both change with changing concentrations of inhibitors which suggests an un-competitive mode of inhibition. Molecular docking studies of these derivatives with the active site of α-glucosidase (PDB ID:1XSK), revealed that these compounds mostly interact with acidic or basic amino acid residues through conventional hydrogen bonds along with other hydrophobic interactions. The binding energy values of compounds 25, 228, and 212 were -5.6, -8.7 and -5.4 kcal.mol-1 whereas RMSD values were 0.6, 2.0, and 1.7 Å, respectively. For comparison, the co-crystallized ligand showed a binding energy value of -6.6 kcal.mol-1 along with an RMSD value of 1.1 Å. Our study predicted several series of compounds as active inhibitors of α-glucosidase including some highly potent inhibitors.
Collapse
Affiliation(s)
- Majid Ali
- Department of Chemistry, COMSATS University Islamabad, KPK, Abbottabad, Pakistan
- Department of Chemistry, Higher Education Department, Government Postgraduate College No.1, Abbottabad, KP, Pakistan
| | - Khuram Malik
- Department of Chemistry, COMSATS University Islamabad, KPK, Abbottabad, Pakistan
| | - Asma Zaidi
- Department of Chemistry, COMSATS University Islamabad, KPK, Abbottabad, Pakistan
| | - Umar Farooq
- Department of Chemistry, COMSATS University Islamabad, KPK, Abbottabad, Pakistan
| | - Syed Majid Bukhari
- Department of Chemistry, COMSATS University Islamabad, KPK, Abbottabad, Pakistan
| | - Zahid Majeed
- Faculty of Science, Department of Biotechnology, The University of Azad Jammu and Kashmir, Chehla Campus, Muzaffarabad, Pakistan
| | - Mater H. Mahnashi
- Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia
| | - Shamyla Nawazish
- Department of Environmental Sciences, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, Pakistan
| | | | | |
Collapse
|
4
|
Kolcuoglu Y, Bekircan O, Fazli H, Sahin E, Ture A, Akdemir A, Hamarat Sanlier S. Design and synthesis of new heterocyclic compounds containing 5-[(1 H-1,2,4-triazol-1-yl)methyl]-3 H-1,2,4-triazole-3-thione structure as potent hEGFR inhibitors. J Biomol Struct Dyn 2023; 41:12753-12767. [PMID: 36688370 DOI: 10.1080/07391102.2023.2167113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Accepted: 01/06/2023] [Indexed: 01/24/2023]
Abstract
EGFR is one of the important mediators of the signaling cascade that determines key roles in various biological processes such as growth, differentiation, metabolism and apoptosis in the cell in response to external and internal stimuli. In recent years, it has been proven that although this enzyme activity is tightly regulated in normal cells, if the enzyme activity cannot be controlled, it can lead to malignancy. EGFR is also considered a prominent macromolecule in targeted cancer chemotherapy. For this purpose, a comprehensive modeling studies were conducted against EGFR protein and novel molecules containing 5-[(1H-1,2,4-triazol-1-yl)methyl]-3H-1,2,4-triazole-3-thione structure were suggested to be synthesized. Among the synthesized molecules, compounds 7c, 8c, 8f and 8g were determined to have significant IC50 values. Compound 8g was found to have the IC50 value closest to the very well-known EGFR inhibitor Gefitinib with its noncompetitive inhibition form. Ki value of compound 8g was calculated as 0.00232 µM.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Yakup Kolcuoglu
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey
| | - Olcay Bekircan
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey
| | - Hilal Fazli
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey
| | - Emine Sahin
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey
| | - Aslı Ture
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey
| | - Atilla Akdemir
- Computer-Aided Drug Discovery Laboratory, Department of Pharmacology, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Turkey
| | - Senay Hamarat Sanlier
- Biochemistry Department, Faculty of Science, Ege University, Izmir, Turkey
- Center for Drug Research, Development and Pharmacokinetic Applications (ARGEFAR), Ege University, Izmir, Turkey
| |
Collapse
|
5
|
Chu J, Yang R, Cheng W, Cui L, Pan H, Liu J, Guo Y. Semisynthesis, biological activities, and mechanism studies of Mannich base analogues of magnolol/honokiol as potential α-glucosidase inhibitors. Bioorg Med Chem 2022; 75:117070. [PMID: 36327695 DOI: 10.1016/j.bmc.2022.117070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2022] [Revised: 10/09/2022] [Accepted: 10/17/2022] [Indexed: 11/16/2022]
Abstract
Magnolol and honokiol, derived from a Magnolia officinalis Rehd. et Wils, are a class of natural biphenolic lignans. Currently, the discovery of new α-glucosidase inhibitors from natural analogues is of interest. Here, four series of thirty new Mannich base analogues of magnolol/honokiol were prepared and evaluated for their α-glucosidase inhibitory activities. Among these Mannich base analogues of magnolol/honokiol, 3k and 3l exhibited more potent inhibitory effects on α-glucosidase than the reference drug acarbose, and their IC50 values were 14.94 ± 0.17 µM and 13.78 ± 1.42 µM, respectively. Some interesting structure-activity relationships (SARs) were also analyzed. The enzyme inhibition kinetics indicated that 3k and 3l were noncompetitive inhibitors. This result was in agreement with molecular docking studies, where the binding sites of 3k and 3l to α-glucosidase were different from that of the competitive inhibitor acarbose to α-glucosidase. Moverover, compounds 3k and 3l exhibited low toxicity to normal cells (LO2). Thus, analogues 3k and 3l could be deeply developed for the discovery of natural products based antidiabetic candidates.
Collapse
Affiliation(s)
- Junyan Chu
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, PR China
| | - Ruige Yang
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, PR China
| | - Wanqing Cheng
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, PR China
| | - Liping Cui
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, PR China
| | - Hanchen Pan
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, PR China
| | - Jifeng Liu
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, PR China.
| | - Yong Guo
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, PR China.
| |
Collapse
|
6
|
Castro Jara M, Silva ACA, Ritter M, da Silva AF, Gonçalves CL, dos Santos PR, Borja LS, de Pereira CMP, da Silva Nascente P. Dihydropyrimidinones Against Multiresistant Bacteria. Front Microbiol 2022; 13:743213. [PMID: 35369453 PMCID: PMC8973396 DOI: 10.3389/fmicb.2022.743213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2021] [Accepted: 02/14/2022] [Indexed: 11/17/2022] Open
Abstract
The increase in bacterial resistance to antimicrobials has led to high morbidity and mortality rates, posing a major public health problem, requiring the discovery of novel antimicrobial substances. The biological samples were identified as the Gram-negative bacilli Acinetobacter baumannii, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Morganella morgannii, Pseudomonas aeruginosa and Serratia marcescens and the Gram-positive cocci Enterococcus faecium, and Staphylococcus aureus, all of them resistant to at least three classes of antimicrobials. The antibacterial activity of the compounds was checked in vitro by determining the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) by the broth microdilution method and plating in brain heart infusion (BHI) agar, respectively. The chemical characterization of the compounds was performed by measuring the melting point and gas chromatography coupled with mass spectrometry (GC–MS) on a Shimadzu GC–MS-QP system 2010SE. Synthetic compounds showed antimicrobial activity against Gram-positive cocci at MIC concentrations 0.16–80 μg/ml and Gram-negative bacilli at MIC concentrations 23.2–80 μg/ml. Enterococcus faecium and S. aureus had the best MIC values. The results of the cytotoxicity test indicated that the synthetic compounds showed no significant difference in three concentrations tested (5, 20, and 80 μg/ml), allowing cell viability not different from that assigned to the control, without the tested compounds. In this context, the development of DHPM derivatives brings an alternative and perspective on effectiveness of drugs as potential future antimicrobial agents.
Collapse
Affiliation(s)
- Marisa Castro Jara
- Postgraduate Program in Biochemistry and Bioprospecting, Federal University of Pelotas, Pelotas, Brazil
- Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, Brazil
- *Correspondence: Marisa Castro Jara,
| | - Allison Carlos Assunção Silva
- Lipidomics and Bioorganics Laboratory, Center for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, Pelotas, Brazil
| | - Marina Ritter
- Lipidomics and Bioorganics Laboratory, Center for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, Pelotas, Brazil
| | | | - Carolina Lambrecht Gonçalves
- Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, Brazil
| | - Pedro Rassier dos Santos
- Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, Brazil
| | - Luciano Sisconetto Borja
- Lipidomics and Bioorganics Laboratory, Center for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, Pelotas, Brazil
| | - Cláudio Martin Pereira de Pereira
- Lipidomics and Bioorganics Laboratory, Center for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, Pelotas, Brazil
| | - Patrícia da Silva Nascente
- Postgraduate Program in Biochemistry and Bioprospecting, Federal University of Pelotas, Pelotas, Brazil
- Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, Brazil
| |
Collapse
|
7
|
Design, synthesis, in vitro evaluation, and docking studies on ibuprofen derived 1,3,4-oxadiazole derivatives as dual α-glucosidase and urease inhibitors. Med Chem Res 2022. [DOI: 10.1007/s00044-021-02814-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
8
|
Vanjare BD, Mahajan PG, Dige NC, Raza H, Hassan M, Han Y, Kim SJ, Seo SY, Lee KH. Novel 1,2,4-triazole analogues as mushroom tyrosinase inhibitors: synthesis, kinetic mechanism, cytotoxicity and computational studies. Mol Divers 2021; 25:2089-2106. [PMID: 32399854 DOI: 10.1007/s11030-020-10102-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Accepted: 04/29/2020] [Indexed: 02/06/2023]
Abstract
We have created a novel series of mushroom tyrosinase inhibitors with 1,2,4-triazole as fundamental skeleton. The target compound 1,2,4-triazol-3-ylthio)-N-phenyl acetamide derivatives 9(a-l) were synthesized by the reaction of 4- and 5-substituted 1,2,4-triazole-3-thiol derivatives 6(a-c) with 2-chloro-N-sub/un-substituted phenyl acetamide derivatives 8(a-d) under basic condition. By using the analytical techniques for instance, FTIR, LC-MS, 1H NMR and 13C NMR, the structural verification was evaluated. The novel series of the target compounds 9(a-l) has been scanned for biological activity (mushroom tyrosinase inhibition potential) which demonstrates adequate results. Interestingly, compound 9k (IC50 = 0.0048 ± 0.0016 µM) exhibits 3500 times more activity compared with standard drug kojic acid (IC50 = 16.8320 ± 1.1600 µM) against mushroom tyrosinase inhibitor. Furthermore, the cytotoxicity experiment was carried out for the highly effective target compounds (9d, 9i, 9j and 9k) by using MTT assay method for A375 human melanoma cells to define the nontoxic performance of the most effective compounds ranging from 1 to 25 µM. Furthermore, the molecular docking study delivers the thought concerning the interface of the ligand with an enzyme. Also, the dynamic simulation was accomplished for compound 9k to govern the plausible binding model.
Collapse
Affiliation(s)
- Balasaheb D Vanjare
- Department of Chemistry, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea
| | - Prasad G Mahajan
- Department of Chemistry, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea
| | - Nilam C Dige
- Department of Biological Sciences, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea
| | - Hussain Raza
- Department of Biological Sciences, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea
| | - Mubashir Hassan
- Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, 54590, Pakistan
| | - Yohan Han
- Department of Biological Sciences, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea
| | - Song Ja Kim
- Department of Biological Sciences, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea
| | - Sung-Yum Seo
- Department of Biological Sciences, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea
| | - Ki Hwan Lee
- Department of Chemistry, Kongju National University, Gongju, Chungnam, 32588, Republic of Korea.
| |
Collapse
|
9
|
Peytam F, Takalloobanafshi G, Saadattalab T, Norouzbahari M, Emamgholipour Z, Moghimi S, Firoozpour L, Bijanzadeh HR, Faramarzi MA, Mojtabavi S, Rashidi-Ranjbar P, Karima S, Pakraad R, Foroumadi A. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase. Sci Rep 2021; 11:11911. [PMID: 34099819 PMCID: PMC8184976 DOI: 10.1038/s41598-021-91473-z] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2021] [Accepted: 05/20/2021] [Indexed: 11/23/2022] Open
Abstract
In an attempt to find novel, potent α-glucosidase inhibitors, a library of poly-substituted 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines 3a-ag have been synthesized through heating a mixture of 2-aminobenzimidazoles 1 and α-azidochalcone 2 under the mild conditions. This efficient, facile protocol has been resulted into the desirable compounds with a wide substrate scope in good to excellent yields. Afterwards, their inhibitory activities against yeast α-glucosidase enzyme were investigated. Showing IC50 values ranging from 16.4 ± 0.36 µM to 297.0 ± 1.2 µM confirmed their excellent potency to inhibit α-glucosidase which encouraged us to perform further studies on α-glucosidase enzymes obtained from rat as a mammal source. Among various synthesized 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines, compound 3k exhibited the highest potency against both Saccharomyces cerevisiae α-glucosidase (IC50 = 16.4 ± 0.36 μM) and rat small intestine α-glucosidase (IC50 = 45.0 ± 8.2 μM). Moreover, the role of amine moiety on the observed activity was studied through substituting with chlorine and hydrogen resulted into a considerable deterioration on the inhibitory activity. Kinetic study and molecular docking study have confirmed the in-vitro results.
Collapse
Affiliation(s)
- Fariba Peytam
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | | | - Toktam Saadattalab
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Maryam Norouzbahari
- Faculty of Medicine, Eastern Mediterranean University, via Mersin 10, Famagusta, Northern Cyprus, Turkey
| | - Zahra Emamgholipour
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Setareh Moghimi
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Loghman Firoozpour
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Hamid Reza Bijanzadeh
- Department of Environmental Sciences, Faculty of Natural Resources and Marine Sciences, Tarbiat Modares University, Tehran, Iran
| | - Mohammad Ali Faramarzi
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Somayeh Mojtabavi
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Saeed Karima
- Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran
| | - Roya Pakraad
- Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran
| | - Alireza Foroumadi
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
10
|
Gultekin E, Bekircan O, Kolcuoğlu Y, Akdemir A. Synthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis. Arch Pharm (Weinheim) 2021; 354:e2100058. [PMID: 33900640 DOI: 10.1002/ardp.202100058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2021] [Revised: 03/29/2021] [Accepted: 04/01/2021] [Indexed: 01/23/2023]
Abstract
Tyrosinase inhibition is very important in controlling melanin synthesis. If melanin synthesis is not controlled in metabolism, an unwanted increase in melanin synthesis occurs. As melanin plays a role in the formation of skin color, its unusual levels cause some skin disorders such as pregnancy scars, age spots, and especially skin cancer (melanoma). However, the tyrosinase activity is also related to Parkinson's disease and some neurodegenerative diseases. For all these reasons, the medicinal as well as the cosmetic industries focus on research on tyrosinase inhibitors for the treatment of skin disorders and some neurodegenerative diseases. In this study, 32 new 1,2,4-triazole-(thio)semicarbazide hybrid molecules (6a-p and 7a-p) were synthesized, starting from 4-amino-1-pentyl-3-phenyl-1H-1,2,4-triazole-5(4H)-one. These compounds were evaluated for their inhibitory activity against mushroom tyrosinase. The results indicated that 6h, 6m, 6n, and 6p exhibited the most effective inhibitory activity, with IC50 values of 0.00162 ± 0.0109, 0.00166 ± 0.0217, 0.00165 ± 0.019, and 0.00197 ± 0.0063 μM, respectively, compared with kojic acid as the reference drug (IC50 = 14.09 ± 0.02 μM). Also, molecular docking analyses were performed to suggest possible binding poses for the ligands. As a result, derivatives 6h, 6m, 6n, and 6p can be used as promising tyrosinase inhibitor candidates in the medicinal, cosmetics, or food industries.
Collapse
Affiliation(s)
- Ergün Gultekin
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey
| | - Olcay Bekircan
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey
| | - Yakup Kolcuoğlu
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey
| | - Atilla Akdemir
- Computer-Aided Drug Discovery Laboratory, Department of Pharmacology, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Turkey
| |
Collapse
|
11
|
Affiliation(s)
- Gülay Akyüz
- Department of Chemistry, Art and Science Faculty Recep Tayyip Erdoğan University Rize Turkey
| |
Collapse
|
12
|
Kumar A, Chauhan S. Pancreatic lipase inhibitors: The road voyaged and successes. Life Sci 2021; 271:119115. [PMID: 33515565 DOI: 10.1016/j.lfs.2021.119115] [Citation(s) in RCA: 62] [Impact Index Per Article: 20.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Revised: 01/20/2021] [Accepted: 01/21/2021] [Indexed: 01/26/2023]
Abstract
Human pancreatic lipase (triacylglycerol acyl hydrolase EC3.1.1.3) is the most widely studied member of the human lipase superfamily related to carboxyl esterase. It is secreted from the acinar cell of pancreas and has strong preference for triacylglycerides over cholesterol esters, phospholipids, and galactolipids. Apart from the hydrolysis of triacylglycerides, pancreatic lipase may cause the hydrolysis of retinyl esters in vivo. So, it is very much evidenced that pancreatic lipase with its cofactor colipase has prominent role in efficient digestion of dietary fat. Hence, the modulation of human pancreatic lipase may represent a new insight in the discovery of a number of therapeutics that can inhibit the absorption of fat in body and can be used in obesity and other related metabolic disorders. Even, the only Food and drug administration (FDA) approved antiobesity drug, orlistat, is also an inhibitor of pancreatic lipase. This review summarizes studies about structure, mechanistic approach of pancreatic lipase enzyme while emphasizing on the various synthetic pancreatic lipase inhibitors with their structure activity relationship (SAR).
Collapse
Affiliation(s)
- Ashwani Kumar
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India
| | - Shilpi Chauhan
- Lloyd Institute of Management and Technology (Pharm.), U.P., India.
| |
Collapse
|
13
|
Farooq S, Mazhar A, Ihsan-Ul-Haq, Ullah N. One-pot multicomponent synthesis of novel 3, 4-dihydro-3-methyl-2(1H)-quinazolinone derivatives and their biological evaluation as potential antioxidants, enzyme inhibitors, antimicrobials, cytotoxic and anti-inflammatory agents. ARAB J CHEM 2020. [DOI: 10.1016/j.arabjc.2020.10.039] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
|
14
|
Ozdemir Y, Bekircan O, Baltaş N, Menteşe E. Synthesis and pancreatic lipase inhibitory activities of some 1,2,4‐triazol‐5(3)‐one derivatives. J Heterocycl Chem 2020. [DOI: 10.1002/jhet.4130] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
- Yusuf Ozdemir
- Department of Chemistry, Faculty of Science Karadeniz Technical University Trabzon Turkey
| | - Olcay Bekircan
- Department of Chemistry, Faculty of Science Karadeniz Technical University Trabzon Turkey
| | - Nimet Baltaş
- Department of Chemistry, Art and Science Faculty Recep Tayyip Erdogan University Rize Turkey
| | - Emre Menteşe
- Department of Chemistry, Art and Science Faculty Recep Tayyip Erdogan University Rize Turkey
| |
Collapse
|
15
|
Fatih Yılmaz, Menteşe E, Baltaş N. Synthesis and Biological Evaluation of Some Succinimide Hybrid Molecules. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2020. [DOI: 10.1134/s1068162019060402] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
16
|
Menteşe E, Baltaş N, Bekircan O. Synthesis and kinetics studies of
N′
‐(2‐(3,5‐disubstituted‐4
H
‐1,2,4‐triazol‐4‐yl)acetyl)‐6/7/8‐substituted‐2‐oxo‐2
H
‐chromen‐3‐carbohydrazide derivatives as potent antidiabetic agents. Arch Pharm (Weinheim) 2019; 352:e1900227. [DOI: 10.1002/ardp.201900227] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 09/11/2019] [Accepted: 09/22/2019] [Indexed: 02/01/2023]
Affiliation(s)
- Emre Menteşe
- Department of Chemistry, Faculty of Arts and SciencesRecep Tayyip Erdogan University Rize Turkey
| | - Nimet Baltaş
- Department of Chemistry, Faculty of Arts and SciencesRecep Tayyip Erdogan University Rize Turkey
| | - Olcay Bekircan
- Department of Chemistry, Faculty of SciencesKaradeniz Technical University Trabzon Turkey
| |
Collapse
|
17
|
Dhameja M, Gupta P. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview. Eur J Med Chem 2019; 176:343-377. [DOI: 10.1016/j.ejmech.2019.04.025] [Citation(s) in RCA: 94] [Impact Index Per Article: 18.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2019] [Revised: 03/19/2019] [Accepted: 04/10/2019] [Indexed: 01/18/2023]
|
18
|
Synthesis of 1,2,4-triazole-5-on derivatives and determination of carbonic anhydrase II isoenzyme inhibition effects. Bioorg Chem 2019; 83:170-179. [DOI: 10.1016/j.bioorg.2018.10.042] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2018] [Revised: 10/19/2018] [Accepted: 10/22/2018] [Indexed: 01/04/2023]
|
19
|
Menteşe E, Akyüz G, Yılmaz F, Baltaş N, Emirik M. Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors. Arch Pharm (Weinheim) 2018; 351:e1800182. [PMID: 30375666 DOI: 10.1002/ardp.201800182] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2018] [Revised: 10/02/2018] [Accepted: 10/10/2018] [Indexed: 11/08/2022]
Abstract
A new series of quinazolinone hybrid molecules containing coumarin, furan, 1,2,4-triazole and 1,2,4-thiadiazole rings was designed, synthesized, and screened for their urease inhibition activities. All newly synthesized compounds showed outstanding urease inhibitory potentials with IC50 values ranging between 1.26 ± 0.07 and 7.35 ± 0.31 μg/mL. Among the series, coumarin derivatives (10a-d) exhibited the best inhibitory effect against urease in the range of IC50 = 1.26 ± 0.07 to 1.82 ± 0.10 μg/mL, when compared to standard urease inhibitors such as acetohydroxamic acid and thiourea (IC50 = 21.05 ± 0.96 and 15.08 ± 0.71 μg/mL, respectively). Molecular docking studies were also performed to analyze the binding mode of compound 10b, and supported the experimental results.
Collapse
Affiliation(s)
- Emre Menteşe
- Faculty of Arts and Sciences, Department of Chemistry, Recep Tayyip Erdogan University, Rize, Turkey
| | - Gülay Akyüz
- Faculty of Arts and Sciences, Department of Chemistry, Recep Tayyip Erdogan University, Rize, Turkey
| | - Fatih Yılmaz
- Department of Chemistry and Chemical Processing Technology, Vocational School of Technical Studies, Recep Tayyip Erdogan University, Rize, Turkey
| | - Nimet Baltaş
- Faculty of Arts and Sciences, Department of Chemistry, Recep Tayyip Erdogan University, Rize, Turkey
| | - Mustafa Emirik
- Faculty of Arts and Sciences, Department of Chemistry, Recep Tayyip Erdogan University, Rize, Turkey
| |
Collapse
|
20
|
Use of Simplified Molecular Input Line Entry System and molecular graph based descriptors in prediction and design of pancreatic lipase inhibitors. Future Med Chem 2018; 10:1603-1622. [DOI: 10.4155/fmc-2018-0024] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Aim: The inhibition of pancreatic lipase (PL) enzyme is the most explored strategy for the treatment of obesity. The present study describes the development of quantitative structure–activity relationship (QSAR) models for a diverse set of 293 PL inhibitors by means of the Monte Carlo optimization technique. Methodology & results: The hybrid optimal descriptors were used to build QSAR models with three subsets of three splits. The developed QSAR models were further validated with corresponding external sets. The best QSAR model has the following statistical particulars: R2 = 0.752, Q LOO 2 = 0 . 736 for the test set and R2 = 0.768, Q F 1 2 = 0 . 628 , Q F 2 2 = 0 . 621 for the validation set. Conclusion: The developed QSAR models were robust, stable and predictive and led to the design of novel PL inhibitors.
Collapse
|
21
|
Biersack B, Ahmed K, Padhye S, Schobert R. Recent developments concerning the application of the Mannich reaction for drug design. Expert Opin Drug Discov 2017; 13:39-49. [PMID: 29137490 DOI: 10.1080/17460441.2018.1403420] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
INTRODUCTION The versatile multicomponent Mannich reaction occupies a salient position in organic chemistry and drug design. Sound knowledge of its scope and variations and of the biological activities of Mannich bases is crucial for the development and improvement of drugs for various diseases. Areas covered: The following article provides an overview of the latest developments in the field of drugs based on the Mannich reaction. Web-based literature searching tools such as PubMed and SciFinder were applied to obtain useful articles. In addition, pertinent literature that was recently published by the authors is discussed in this manuscript. The chemical structures of bioactive Mannich bases are also given. Expert opinion: The Mannich reaction represents a feasible and cost-effective procedure with great potential for drug development. Several newly discovered Mannich bases exhibit sound activities against various human diseases as well as favorable pharmacokinetics. Thus, scientific research about Mannich bases is prospering and appears very attractive both for chemists and for clinicians.
Collapse
Affiliation(s)
- Bernhard Biersack
- a Organic Chemistry Laboratory , University of Bayreuth , Bayreuth , Germany
| | - Khursheed Ahmed
- b Department of Chemistry , Abeda Inamdar Senior College , Pune , India
| | - Subhash Padhye
- c Interdisciplinary Science and Technology Research Academy (ISTRA) , Pune , India
| | - Rainer Schobert
- a Organic Chemistry Laboratory , University of Bayreuth , Bayreuth , Germany
| |
Collapse
|
22
|
Wos M, Miazga-Karska M, Kaczor AA, Klimek K, Karczmarzyk Z, Kowalczuk D, Wysocki W, Ginalska G, Urbanczyk-Lipkowska Z, Morawiak M, Pitucha M. Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity. Biomed Pharmacother 2017; 93:1269-1276. [DOI: 10.1016/j.biopha.2017.07.049] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Revised: 06/12/2017] [Accepted: 07/11/2017] [Indexed: 10/19/2022] Open
|